Hua Medicine (Shanghai) Ltd. (HUMDF) Financials
HUMDF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 210.2 million | 66.3 million |
| June 30, 2025 | 198.2 million | 50.4 million |
| Dec. 31, 2024 | 209.2 million | 227.8 million |
| June 30, 2024 | 227.7 million | 232.3 million |
HUMDF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | ? | ? |
| June 30, 2025 | -11.8 million | 686198 |
| Dec. 31, 2024 | -26.4 million | 614442 |
| June 30, 2024 | -31.3 million | 1.0 million |
HUMDF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| Dec. 31, 2025 | ? |
| June 30, 2025 | 165.3 million |
| Dec. 31, 2024 | -14.8 million |
| June 30, 2024 | -19.6 million |
HUMDF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 156.2 million | 31.5 million | 4.6 million |
| June 30, 2025 | 142.8 million | 23.2 million | 8.1 million |
| Dec. 31, 2024 | 156.1 million | 19.0 million | 8.7 million |
| June 30, 2024 | 184.2 million | 23.9 million | 4.6 million |
HUMDF Shares Outstanding
HUMDF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | - | 11.2 million | 22.9 million | - |
| June 30, 2025 | - | 9.2 million | 16.4 million | 9.0 million |
| Dec. 31, 2024 | 255915 | 13.1 million | 20.2 million | 12.6 million |
| June 30, 2024 | 132382 | 16.5 million | 16.8 million | 8.4 million |
HUMDF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2025 | 38.7 million | 15.9 million |
| June 30, 2025 | 30.4 million | 13.9 million |
| Dec. 31, 2024 | 21.0 million | 10.4 million |
| June 30, 2024 | 14.1 million | 7.6 million |
HUMDF
Price: $0.43
52 week price:
Earnings Per Share: 0.16 USD
P/E Ratio: 2.58
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 430.9 million